EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cardiotoxicity of Agents Used in Patients With Breast Cancer

Paola Zagami iD, Dario Trapani iD, Eleonora Nicolò iD, Chiara Corti iD, Carmine Valenza, Carmen Criscitiello, Giuseppe Curigliano iD, Lisa Anne Carey iD

JCO Oncology Practice · 2024

DOI: 10.1200/op.23.00494 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JCO Oncology Practice, 2024. Verfasst von Paola Zagami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hematology, University of Milano, Milan, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Cardiovascular Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer and cardiovascular diseases are the two major causes of mortality, morbidity, and disability worldwide. The improvement in effective therapeutic options for the management of breast cancer (BC) has led to an increased number of BC survivors, who can experience long-term toxicities from cancer treatments. Adverse events including cardiovascular toxicities must be considered in light of effectiveness of recently approved drugs for BC treatment, including elacestrant, tucatinib, neratinib, olaparib, the immune checkpoint inhibitors, trastuzumab deruxtecan, or sacituzumab govitecan. Many cancer drugs affect the cardiovascular system with a range of clinical manifestations. Prompt diagnosis and treatment as well as a multidisciplinary approach involving a cardio-oncologist is optimal for management of these cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAntineoplastic AgentsCardiovascular DiseasesHumansFemaleCardiotoxicity

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Oncology and Hematology, University of Milano, Milan, Italy.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.

ORCID-Profile: Paola Zagami, Dario Trapani, Eleonora Nicolò, Chiara Corti, Giuseppe Curigliano, Lisa Anne Carey

Förderung

  • NCI NIH HHS

Zitieren

APA

Zagami, P., Trapani, D., Nicolò, E., Corti, C., Valenza, C., Criscitiello, C., Curigliano, G., & Carey, L. A. (2024). Cardiotoxicity of Agents Used in Patients With Breast Cancer. JCO Oncology Practice. https://doi.org/10.1200/op.23.00494

Vancouver

Zagami P, Trapani D, Nicolò E, Corti C, Valenza C, Criscitiello C, et al. Cardiotoxicity of Agents Used in Patients With Breast Cancer. JCO Oncology Practice. 2024. doi:10.1200/op.23.00494

BibTeX
@article{Zagami2024,
  author = {Zagami, Paola and Trapani, Dario and Nicolò, Eleonora and Corti, Chiara and Valenza, Carmine and Criscitiello, Carmen and Curigliano, Giuseppe and Carey, Lisa Anne},
  title = {Cardiotoxicity of Agents Used in Patients With Breast Cancer},
  journal = {JCO Oncology Practice},
  year = {2024},
  doi = {10.1200/op.23.00494}
}
Kostenlos starten →